Stevanato Group S.p.A (STVN) Long-Term Deferred Tax (2020 - 2026)
Stevanato Group S.p.A (STVN) posted quarterly Long-Term Deferred Tax of $129.0 million for Q1 2026, up 25.13% year-over-year from $103.1 million in Q1 2025, and up 6.67% quarter-over-quarter from $120.9 million in Q4 2025.
Stevanato Group S.p.A (STVN) Long-Term Deferred Tax (2020 - 2026) Analysis & Trends
Stevanato Group S.p.A (STVN) has reported Long-Term Deferred Tax for 7 consecutive years, with $129.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Long-Term Deferred Tax rose 25.13% year-over-year to $129.0 million; the TTM figure through Mar 2026 stood at $129.0 million (up 25.13% YoY), while the FY2025 annual figure was $120.9 million, up 18.73% from the prior year.
- Long-Term Deferred Tax grew to $129.0 million in Q1 2026 per STVN's latest filing, from $120.9 million in the prior quarter.
- Across five years, Long-Term Deferred Tax topped out at $129.0 million in Q1 2026 and bottomed at $64.0 million in Q1 2022.
- Historically, Long-Term Deferred Tax has averaged $90.9 million across 5 years, with a median of $86.0 million in 2024.
- Annual changes were most pronounced in 2023 — Long-Term Deferred Tax climbed 29.82% — and 2024, when it increased 6.32%.
- Stevanato Group S.p.A's Long-Term Deferred Tax stood at $70.6 million in 2022, then grew by 16.28% to $82.1 million in 2023, then advanced by 24.05% to $101.8 million in 2024, then climbed by 18.73% to $120.9 million in 2025, then rose by 6.67% to $129.0 million in 2026.
- Business Quant data shows STVN's Long-Term Deferred Tax at $129.0 million in Q1 2026, $120.9 million in Q4 2025, and $119.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn |
| 10 | Stevanato Group S.p.A | 6.18 Bn | 6.07 Bn | 100.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 125.03 Mn |
| Mar 31, 2026 | 128.98 Mn |
| Dec 31, 2025 | 120.91 Mn |
| Sep 30, 2025 | 119.71 Mn |
| Jun 30, 2025 | 112.91 Mn |
| Mar 31, 2025 | 103.07 Mn |
| Dec 31, 2024 | 101.84 Mn |
| Sep 30, 2024 | 95.53 Mn |
| Jun 30, 2024 | 89.20 Mn |
| Mar 31, 2024 | 85.98 Mn |
| Dec 31, 2023 | 82.09 Mn |
| Sep 30, 2023 | 77.92 Mn |
| Jun 30, 2023 | 83.89 Mn |
| Mar 31, 2023 | 77.94 Mn |
| Dec 31, 2022 | 70.60 Mn |
| Sep 30, 2022 | 66.24 Mn |
| Jun 30, 2022 | 64.62 Mn |
| Mar 31, 2022 | 64.04 Mn |
| Dec 31, 2021 | 63.95 Mn |
| Sep 30, 2021 | 61.56 Mn |